243 related articles for article (PubMed ID: 21352343)
1. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
[TBL] [Abstract][Full Text] [Related]
2. 9-Cis-retinoic acid exhibits antifibrotic activity via the induction of cyclooxygenase-2 expression and prostaglandin E2 production in scleroderma fibroblasts.
Xiao R; Kanekura T; Yoshida N; Higashi Y; Yan KL; Fukushige T; Kanzaki T
Clin Exp Dermatol; 2008 Jul; 33(4):484-90. PubMed ID: 18462443
[TBL] [Abstract][Full Text] [Related]
3. 5-HT
Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
[TBL] [Abstract][Full Text] [Related]
4. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y
J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
[TBL] [Abstract][Full Text] [Related]
5. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts.
Abraham DJ; Shiwen X; Black CM; Sa S; Xu Y; Leask A
J Biol Chem; 2000 May; 275(20):15220-5. PubMed ID: 10809757
[TBL] [Abstract][Full Text] [Related]
8. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
9. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis].
Bian H; Lv Q; Huang XZ; Hu JL; Yang L; Mao BY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1054-9. PubMed ID: 26591358
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
12. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid.
Razzaque MS; Foster CS; Ahmed AR
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1998-2003. PubMed ID: 12714635
[TBL] [Abstract][Full Text] [Related]
13. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
[TBL] [Abstract][Full Text] [Related]
15. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
18. Effects of enamel matrix derivative and transforming growth factor-β1 on connective tissue growth factor in human periodontal ligament fibroblasts.
Heng NH; Zahlten J; Cordes V; Ong MM; Goh BT; N'Guessan PD; Pischon N
J Periodontol; 2015 Apr; 86(4):569-77. PubMed ID: 25594423
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis.
Higuchi T; Kawaguchi Y; Takagi K; Tochimoto A; Ota Y; Katsumata Y; Ichida H; Hanaoka M; Kawasumi H; Tochihara M; Yamanaka H
Clin Immunol; 2015 Dec; 161(2):333-8. PubMed ID: 26387628
[TBL] [Abstract][Full Text] [Related]
20. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.
Stratton R; Shiwen X; Martini G; Holmes A; Leask A; Haberberger T; Martin GR; Black CM; Abraham D
J Clin Invest; 2001 Jul; 108(2):241-50. PubMed ID: 11457877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
